• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Change in Pihlajalinna’s Management Team: Heikki Tarkkila will assume the role of Chief Commercial Officer

PIHLISRegulatory press release12.02.2026 klo 08.30
Discuss

Pihlajalinna Plc       Stock Exchange Release       12 February 2026 at 8:30 a.m. EET

Change in Pihlajalinna’s Management Team: Heikki Tarkkila will assume the role of Chief Commercial Officer

Heikki Tarkkila (Lic.Med.) has been appointed as Chief Commercial Officer of Pihlajalinna Plc and a member of the Management Team. Tarkkila has had a diverse career at McKinsey from 2018 to 2025. Most recently, as an Associate Partner, he has led McKinsey’s healthcare practice in Finland and served on McKinsey’s Nordic Healthcare leadership team. Prior to this, he co‑founded Carecode Oy and served as the company’s Director responsible for operations and sales between 2014 and 2018. Tarkkila will assume his new role on 1 March 2026.

“Our strategy centres on succeeding together with our partners – corporate clients, insurance companies and the public sector. To support this, we have strengthened our new operating model by establishing a commercial function alongside the Medical and Health Services organisations. Heikki brings us broad expertise needed in commercial thinking and growth leadership, backed by strong experience working with different service providers, insurers, investors and the pharmaceutical industry. I warmly welcome Heikki to Pihlajalinna and to our Management Team”, says Pihlajalinna’s President and CEO Tuomas Hyyryläinen.

“I have worked in healthcare both in Finland and internationally, and I will bring to Pihlajalinna my experience in developing new operating models, utilising technology and driving data‑based leadership. My background as a physician combined with business leadership helps in aligning medical and commercial priorities. I believe that together with Pihlajalinna colleagues and our partners, we can renew healthcare services in a high‑quality and impactful way to meet market needs”, says Heikki Tarkkila.


Pihlajalinna Plc

*******************************
Heikki Tarkkila

born 1988
Medical Doctor, Licentiate of Medicine
Finnish Citizen

Primary working experience

McKinsey 2018–2025
Several roles,
most recently as Associate Partner, healthcare practice

Carecode Oy, 2014–2018
Co-Founder, Head of Operation and Sales

Mehiläinen 2018–2025 (periodic)
General Practitioner, Occupational Healthcare Physician

A photo of Heikki Tarkkila is attached to this release.

Further information:

Tuula Lehto,
Executive Vice President, Communications, Marketing and Sustainability
tel. +358 40 5885 343, tuula.lehto@pihlajalinna.fi

Distribution:
Nasdaq Helsinki Ltd.
Key media
pihlajalinna.fi/en/investors

Pihlajalinna in brief

Pihlajalinna is a healthcare reformer, building effective care pathways and the most attractive corporate culture in the industry. Pihlajalinna is the most committed partner for insurance partners', corporations' and the public sector's success. The Group provides comprehensive, high-quality services through private clinics, hospitals, remote channels, work ability-supporting occupational healthcare as well as social and healthcare solutions for the public sector that deliver overall cost effectiveness. Approximately 4,500 employees and 2,300 practitioners work at Pihlajalinna. In 2025, Pihlajalinna's revenue was 652 million euros. Pihlajalinna's shares are listed on Nasdaq Helsinki Oy. Read more www.pihlajalinna.fi.


Attachments
Tarkkila Heikki.jpg